Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension-Reference-Cited by-同舟云学术

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

Published:2002-12 Issue:6 Volume:37 Page:773-780
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Croquet Vincent,Moal Frédéric,Veal Nary,Wang Jianhua,Oberti Frédéric,Roux Jérôme,Vuillemin Eric,Gallois Yves,Douay Olivier,Chappard Daniel,Calès Paul

Publisher

Elsevier BV

Subject

Hepatology

Reference44 articles.

1. Renin-angiotensin-aldosterone system in cirrhosis;Wilkinson;Gut,1980

2. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver;Ballet;J Pharmacol Exp Ther,1988

3. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites;Arroyo;Eur J Clin Invest,1981

4. Angiotensin II increases portosystemic collateral resistance in portal hypertension;Campbell;J Surg Res,1991

5. Angiotensin receptors and their antagonists;Goodfriend;N Engl J Med,1996

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease;European Journal of Gastroenterology & Hepatology;2024-03-22

2. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats;F1000Research;2024-02-06

3. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation;Journal of Hepatology;2023-11

4. Losartan-IR820-Loaded Polydopamine Nanoparticles for CO₂-Generating Ultrasound Imaging-Guided Photothermal/Photodynamic Therapies of Triple-Negative Breast Cancer;ACS Applied Nano Materials;2023-06-23

5. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats;F1000Research;2023-05-11